Ending the HIV Epidemic for Patient and Healthcare Staff Well-being
Launched by COLUMBIA UNIVERSITY · Mar 14, 2023
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Ending the HIV Epidemic With Equity," aims to tackle the issues of racism and discrimination that affect Black, Indigenous, and People of Color (BIPOC) living with HIV and those who work in healthcare. The study will involve selected clinics funded by the Ryan White HIV/AIDS Program in the Southern and Eastern United States. These clinics will work together to create programs that help reduce the impact of structural racism and discrimination. Participants, including clinic staff and some patients, will take part in training sessions designed to raise awareness and improve the clinic environment. Every six months, they will also complete surveys to track progress over a period of 18 months.
To be eligible for this trial, clinics must primarily serve a BIPOC population and show a strong interest in addressing racism and discrimination. The recruitment is currently ongoing, and there are no specific age or gender restrictions for participants, as the study welcomes everyone. This trial represents an important step in promoting equity in healthcare for people living with HIV, ensuring that everyone receives fair treatment and support.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Selected Ryan White Clinics. Selection based on the following:
- • First, clinic leaders will complete a 15-min Site Characteristics Survey, assessing suitability for participation and clinic comparability for randomization purposes. Staff and leadership at Ryan White clinics will next complete an anonymous 15-minute Eligibility Survey.
- • Within each clinic, both clinic staff and patients will be invited to participate.
- Exclusion Criteria:
- • Non-Ryan White Clinics
- • Clinics not located in the geographical area of interest
- • Clinics that are not interested in participating
About Columbia University
Columbia University, a prestigious Ivy League institution located in New York City, is a leading sponsor of clinical trials dedicated to advancing medical research and improving patient care. With a robust network of research facilities and a commitment to innovation, Columbia University collaborates with a diverse range of healthcare professionals and researchers to explore groundbreaking therapies and treatment methodologies. The university's clinical trials encompass various fields, including oncology, neurology, and public health, aiming to translate scientific discoveries into effective clinical applications. Columbia University is dedicated to maintaining the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants while contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Corina Lelutiu-Weinberger, PhD
Principal Investigator
Columbia University
Felicia A Browne, ScD
Principal Investigator
RTI International
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials